Frontiers in Hematology

Original Research

Accepted on 14 Feb 2025

HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective

in Red Cells, Iron and Erythropoiesis

Sundar Periyavan
Sudha Kumar
Mamatha G N
Santhosh Hegde
Suman Jain
Rakesh Dhanya
Rajat Kumar Agarwal
Lawrence Faulkner

Frontiers in Hematology

doi 10.3389/frhem.2025.1461498

Case Report

Accepted on 12 Feb 2025

Triplet combination with Pirtobrutinib/Venetoclax/Rituximab in Accelerated Phase of Chronic Lymphocytic Leukemia

in Blood Cancer

Andrea Serafin
Alessandro Cellini
Francesco Angotzi
Valeria Ruocco
Arianna Bevilacqua
Marco Pizzi
LIVIO TRENTIN
ANDREA VISENTIN

Frontiers in Hematology

doi 10.3389/frhem.2025.1552200

Editorial

Accepted on 11 Feb 2025

Editorial: Hematopoietic Stress in Stem Cell Homeostasis and Disease Pathogenesis

in Hematopoiesis and Stem Cells

Jing Ma
Hirotaka Matsui
Lijian Shao

Frontiers in Hematology

doi 10.3389/frhem.2025.1571674

101 views

Review

Accepted on 10 Feb 2025

Abnormalities of the primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, coagulation system, and bone marrow microenvironment

in Blood Cancer

Jahan Abdi
Payman Nasr

Frontiers in Hematology

doi 10.3389/frhem.2025.1435193

Mini Review

Published on 07 Feb 2025

The aging hematopoietic stem cell niche: a mini review

in Hematopoiesis and Stem Cells

Xin Gao
Jing Zhang
Owen J. Tamplin

Frontiers in Hematology

doi 10.3389/frhem.2025.1525132

194 views

Case Report

Accepted on 04 Feb 2025

Acquired von Willebrand Disease associated with Smoldering Multiple Myeloma and Hereditary Hemorrhagic Telangiectasia successfully treated with Daratumumab, Pomalidomide, and Dexamethasone: Hitting three birds with one stone?case report

in Blood Cancer

Lemchukwu Amaeshi
Mansour Gergi
Jacqueline Poston

Frontiers in Hematology

doi 10.3389/frhem.2025.1499500

Original Research

Accepted on 04 Feb 2025

FACIT-Fatigue Scale in Patients with Cold Agglutinin Disease: Psychometric Validation and Estimation of Clinically Meaningful Change

in Red Cells, Iron and Erythropoiesis

David Cella
Quentin A Hill
Alia Karaouni
Florence Joly
Timothee Sourdille
Frank Shafer
Marek Wardęcki
Mark Kosinski
Alexander Röth

Frontiers in Hematology

doi 10.3389/frhem.2025.1490130

Original Research

Accepted on 04 Feb 2025

Time to Initiation of Antiresorptive Agents in Multiple Myeloma to Reduce Skeletal Related Events

in Blood Cancer

Amman Bhasin
Adam Finn Binder
Leland Damron
Amry Majeed
Adam Barsouk
Kelly Hughes
Niketa Raj
Abdullateef O Abdulkareem
Tingting Zhan
Divya Polu

Frontiers in Hematology

doi 10.3389/frhem.2025.1521017

Mini Review

Accepted on 03 Feb 2025

The role of Glucocorticoids in Erythropoiesis

in Red Cells, Iron and Erythropoiesis

Lars Lee Perry Hanssen
Deena Iskander

Frontiers in Hematology

doi 10.3389/frhem.2025.1540152

Editorial

Published on 24 Jan 2025

Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations

in Immunobiology and Immunotherapy

Bruno António Cardoso
Natalia Neparidze

Frontiers in Hematology

doi 10.3389/frhem.2025.1548984

267 views

Original Research

Published on 21 Jan 2025

Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study

in Blood Cancer

Sam Salek
Samantha Nier
Zack Pemberton-Whiteley
Tatyana Ionova
Giuseppe Ianni
Giovanni Tripepi
Nick York
Nicole Schroeter
Kathryn Huntley
Michael Rynne

Frontiers in Hematology

doi 10.3389/frhem.2024.1502166

987 views

Case Report

Published on 16 Jan 2025

Case report: VEXAS syndrome: first documented cases in Latin America

in Blood Cancer

Carolina Ottati
Inés Gervaz
Martín Yandian
Matilde Boada
Gabriela Vidal-Senmache
Percy Ortiz-Guerra
Ana I. Catalán
Patricia Kutscher
Diego Lopez
Lilian Diaz

Frontiers in Hematology

doi 10.3389/frhem.2024.1501337

175 views

Case Report

Published on 10 Jan 2025

Case report: A decade-long journey with cyclic thrombocytopenia

in Blood Cancer

Talal Al-Assil
Suhaib Ellythy
Omer A. Idris
Mohammad Omaira

Frontiers in Hematology

doi 10.3389/frhem.2024.1482891

192 views

Original Research

Published on 26 Dec 2024

Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology

in Immunobiology and Immunotherapy

Luce Perie
Selina Stippa
Christoph Saffer
Andrea Hartmann
Mathias Mörgelin
Svante L. H. Zipfel
Marc Thilo Figge
Thorsten Wiech
Christine Skerka
Peter F. Zipfel

Frontiers in Hematology

doi 10.3389/frhem.2024.1469176

483 views

Mini Review

Published on 24 Dec 2024

Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms

in Blood Cancer

Joshua W. Bliss
Spencer Krichevsky
Joseph Scandura
Ghaith Abu-Zeinah

Frontiers in Hematology

doi 10.3389/frhem.2024.1504327

422 views

Case Report

Published on 17 Dec 2024

A patient with concurrent EBV-negative diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: a case report

in Blood Cancer

Monika A. Satoskar
Matthew R. Lordo
Daniel M. Jones
Nicholas B. Nowacki
Jonathan E. Brammer
John C. Reneau
Timothy J. Voorhees

Frontiers in Hematology

doi 10.3389/frhem.2024.1463487

335 views

Navigation group

Articles

HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective

Triplet combination with Pirtobrutinib/Venetoclax/Rituximab in Accelerated Phase of Chronic Lymphocytic Leukemia

Editorial: Hematopoietic Stress in Stem Cell Homeostasis and Disease Pathogenesis

Abnormalities of the primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, coagulation system, and bone marrow microenvironment

The aging hematopoietic stem cell niche: a mini review

Acquired von Willebrand Disease associated with Smoldering Multiple Myeloma and Hereditary Hemorrhagic Telangiectasia successfully treated with Daratumumab, Pomalidomide, and Dexamethasone: Hitting three birds with one stone?case report

FACIT-Fatigue Scale in Patients with Cold Agglutinin Disease: Psychometric Validation and Estimation of Clinically Meaningful Change

Time to Initiation of Antiresorptive Agents in Multiple Myeloma to Reduce Skeletal Related Events

The role of Glucocorticoids in Erythropoiesis

Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations

Impact of leukemia subtype and demographics on patient quality of life in 76 countries: a cross-sectional study

Case report: VEXAS syndrome: first documented cases in Latin America

Case report: A decade-long journey with cyclic thrombocytopenia

Unique target binding by the C-terminal region of FHR1 provides a new perception of aHUS pathology

Leveraging big data and artificial intelligence for smarter trials in myeloproliferative neoplasms

A patient with concurrent EBV-negative diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: a case report